PAF1-mediated transcriptional reprogramming confers docetaxel resistance in advanced prostate cancer. Muniyan S, Vengoji R, Nimmakayala RK, Seshacharyulu P, et al. Cancer Lett 2024 Nov 25:217355. doi: 10.1016/j.canlet.2024.217355.

Read + Share

Amedeo Smart

Independent Medical Education

Muniyan S, Vengoji R, Nimmakayala RK, Seshacharyulu P, et al. PAF1-mediated transcriptional reprogramming confers docetaxel resistance in advanced prostate cancer. Cancer Lett 2024 Nov 25:217355. doi: 10.1016/j.canlet.2024.217355.
PMID: 39603380